Quantcast

Drug Self-administration Markets to 2020

February 14, 2014

DUBLIN, February 14, 2014 /PRNewswire/ –

Research and Markets (http://www.researchandmarkets.com/research/477x2k/drug) have
announced the addition of the “Drug Self-administration Markets to 2020″
[http://www.researchandmarkets.com/research/477x2k/drug ] report to their offering.

(Logo:
http://photos.prnewswire.com/prnh/20130307/600769 )

Therapeutic Indications, Product Strategies, Markets and Forecasts

While alternative methods for delivering therapeutics to patients have had some
notable successes, most drugs continue to be delivered orally. Because they cannot
tolerate the first-pass metabolism of the digestive tract, the recent escalation in new
biological drugs, including antibodies and recombinant proteins, is placing renewed
emphasis on alternate delivery technologies. Now a number of factors are converging to
create both risk and opportunity for drug makers and their delivery device partners. These
include new classes of drugs for previously refractory conditions, the growing trend
toward self-administration for chronic diseases, shifting patient demographics in
industrial countries, caregiver safety legislation, and continued pressure to control
healthcare costs. These factors are giving rise to a new generation of sophisticated,
application-specific injection, inhalation and transdermal drug products designed to
satisfy caregiver and patient preferences while addressing managed care initiatives and
the formulation limitations of new classes of therapeutic drugs. Because of their ability
to safely and reliably satisfy treatment protocols and compliance goals, non-oral drug
delivery products will have a significant impact on the future of drug
self-administration.

Highlights

        - Provides detailed analysis of drug self-administration market segments,
          market dynamics and market demographics
        - Analyzes therapeutic demand drivers and evaluates commercial drug products in
          more than two dozen major self-administration therapeutic segments
        - Analyzes design factors, material selection issues, technologies and market
          development issues for injection devices, inhalation devices and transdermal drug
          products designed for self-administration
        - Charts product data, market share, and forecasts to 2020
        - Profiles self-administration drug product and device participants, their
          product development activities, business strategies, and corporate alliances and
          affiliations

Key Topics Covered:

        Executive Summary

        Drug Market Dynamics

        Evolving Drug Development and Market Factors
        Managed Care and Prescribing Trends
        Drug Self-Administration Demand Factors
        Shifting Patient Demographics
        Chronic Disease and Self-administration
        Biological Drugs Proliferating
        Delivery Device Technology & Evolving

        Drug Self-Administration Product Segments and Market Drivers

        Injectable Drug Self-Administration

        Market Sector Dynamics
        The Shift to Prefilled Devices
        Device Selection Factors
        Market Segmentation & Cost
        Product Features & Ease of Use
        Custom Device Designs & Branding
        Prefilled Syringes (PFS)
        Glass PFS
        Plastic PFS
        Prospects for Autoinjectors
        Key PFS Therapeutic Segments
        The PFS Supply Chain
        PFS Supplier Profiles
        Pen Injectors
        Reusable Pens
        Disposable Pens
        Key Pen Injector Therapeutic Segments
        The Top Ten Pen Injector Drug Products
        Five Segments Driving Pen Injector Growth
        Pen Injector Company Profiles
        Needle-free Injectors (NFI)
        Reusable NFI
        Disposable
        Competitive NFI Therapeutic Segments
        Needle-free Company Profiles

        Inhaled Drug Self-Administration Products

        Market Sector Dynamics
        The Upper Respiratory Market
        Established Therapeutic Targets
        Dual Drug Inhalers
        The Systemic/Deep Lung Market
        Established Markets
        Emerging Therapies
        Inhaler Technology and Market Prospects
        Inhaler Product Segments
        Dry Powder Inhalers
        Device Design Factors
        Powder Technology
        Packaging Issues
        DPI Device Company Profiles
        Metered Dose Inhalers
        Manual Devices
        Breathe Actuated Designs
        MDI Device Company Profiles
        Nebulizers
        Established Nebulizer Therapies
        Evolving Nebulizer Technology
        Nebulizer Device Company Profiles
        Performance Factors
        Bioavailability
        Dose Reproducibility
        Active Compound Stability

        Transdermal Drug Self-Administration

        Market Sector Dynamics
        Traditional Patch Markets
        Emerging Markets
        Transdermal Patch Market Drivers
        Prescription Patch Design & Technology
        Passive Patch Architecture
        Passive Transdermal Patch Design
        Passive Patch Construction
        Active Transport Patch Technologies
        Iontophoresis
        Electroporation
        Microporation
        Mechanical Arrays
        Radio Frequency
        Thermal/Heat
        Ultrasound
        Prescription Patch Development Factors
        Key Transdermal Therapeutic Markets
        Transdermal Product Company Profiles

        Drug Self-Administration - Therapeutic Sector Analysis & Forecasts

        ADHD
        Anticoagulants
        Arthritis
        Asthma/COPD
        Cardiovascular
        Contraception
        Cystic Fibrosis
        Diabetes
        Hematopoietics
        Hepatitis
        Hormone Therapy/Replacement
        Multiple Sclerosis
        Neurology
        Osteoporosis
        Pain Management
        Psoriasis
        Sexual Health

        Company Profiles

For more information visit http://www.researchandmarkets.com/research/477x2k/drug

Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net


    Photo: 

http://photos.prnewswire.com/prnh/20130307/600769

SOURCE Research and Markets


Source: PR Newswire



comments powered by Disqus